Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Heterocyclic leukocyte adhesion inhibitors in early development at Aventis

March 27, 2000

Hokuriku Seiyaku scientists discover new cytokine inhibitors

March 27, 2000

Hydroxamic acid-based MMP inhibitors developed at Pfizer

March 27, 2000

International patent issued for SB's novel C3A receptor ligands and their use in inflammation

March 23, 2000

Gliatech's anticomplement MAb reduces inflammation in preclinical model

March 23, 2000

Early clinical results presented for SB-242235 at scientific meeting

March 22, 2000

Lilly presents another series of indole sPLA2 inhibitors

March 22, 2000

Spanish lab describes early research results in the area of COX-2 inhibitors

March 22, 2000

AstraZeneca synthesizes amide derivatives as cytokine production inhibitors

March 22, 2000

Lilly discloses new indole sPLA2 inhibitors

March 21, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...